论文部分内容阅读
过去治疗肺结核惯用PAS+异菸肼、初期加用链霉素的18个月疗法。但这种长期的化学治疗有许多缺点。如对病人不方便,患者讨厌服药以及需长期随诊观察等,且PAS、链霉素发生副作用较多。利福平是有效的杀菌抗结核药物,与异菸肼合用是个高度有效的抗结核疗法。本文分组观察了利福平+异菸肼、初期加用链霉素或乙胺丁醇疗法,探讨是否可以缩短疗程。
The past treatment of pulmonary tuberculosis with PAS + isoniazid, an initial 18 months with streptomycin therapy. However, this long-term chemotherapy has many disadvantages. Such as inconvenient to the patient, patients hate medication and need long-term follow-up observation, and more side effects of PAS, streptomycin. Rifampicin is a potent antiseptic anti-TB drug and is a highly effective anti-TB therapy in combination with isoniazid. This article was divided into groups observed rifampicin + isoniazid, initially added streptomycin or ethambutol therapy to explore whether it can shorten the course of treatment.